Make no bones about it: cells could soon be reprogrammed to grow replacement bones?

Bibliography

• Nelson TJ, Behfar A, Terzic A. Stem cells: biologics for regeneration. Clin Pharmacol Ther 2008;84:620-3
   PubMed Web of Science ®Google Scholar
• Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7
   PubMed Web of Science ®Google Scholar
• Tachibana M, Amato P, Sparman M, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 2013;153:1228-38
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72
   PubMed Web of Science ®Google Scholar
• Chou BK, Mali P, Huang X, et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 2011;21:518-29
   PubMed Web of Science ®Google Scholar
• Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010;7:618-30
   PubMed Web of Science ®Google Scholar
• Boulting GL, Kiskinis E, Croft GF, et al. A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 2011;29:279-86
   PubMed Web of Science ®Google Scholar
• U.S. Markets for Orthopedic Biomaterials for Bone Repair and Regeneration. MedTech Insight 2013
   Google Scholar
• Giuliani A, Manescu A, Langer M, et al. Three Years After Transplants in Human Mandibles, Histological and In-Line Holotomography Revealed That Stem Cells Regenerated a Compact Rather Than a Spongy Bone: biological and Clinical Implications. Stem Cells Trans Med 2013;2:316-24
   PubMed Web of Science ®Google Scholar
• Trautvetter W, Kaps C, Schmelzeisen R, et al. Tissue-engineered polymer-based periosteal bone grafts for maxillary sinus augmentation: five-year clinical results. J Oral Maxillofac Surg 2011;69:2753-62
   PubMed Web of Science ®Google Scholar
• Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001;344:385-6
   PubMed Web of Science ®Google Scholar
• Lee J, Sung HM, Jang JD, et al. Successful reconstruction of 15-cm segmental defects by bone marrow stem cells and resected autogenous bone graft in central hemangioma. J Oral Maxillofac Surg 2010;68:188-94
   PubMed Web of Science ®Google Scholar
• Sándor GK, Tuovinen VJ, Wolff J, et al. Adipose stem cell tissue-engineered construct used to treat large anterior mandibular defect: a case report and review of the clinical application of good manufacturing practice-level adipose stem cells for bone regeneration. J Oral Maxillofac Surg 2013;71:938-50
   PubMed Web of Science ®Google Scholar
• d'Aquino R, De Rosa A, Lanza V, et al. Human mandible bone defect repair by the grafting of dental pulp stem/progenitor cells and collagen sponge biocomplexes. Eur Cell Mater 2009;18:75-83
   PubMed Web of Science ®Google Scholar
• James D, Nam HS, Seandel M, et al. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nat Biotechnol 2010;28:161-6
   PubMed Web of Science ®Google Scholar
• Barberi T, Willis LM, Socci ND, et al. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2005;2:e161
   PubMedGoogle Scholar
• de Peppo GM, Sjovall P, Lennerås M, et al. Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Eng Part A 2010;16:3413-26
   PubMed Web of Science ®Google Scholar
• de Peppo GM, Thomsen P, Karlsson C, et al. Human progenitor cells for bone engineering applications. Curr Mol Med 2013;13:723-34
   PubMed Web of Science ®Google Scholar
• de Peppo GM, Svensson S, Lennerås M, et al. Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications. Tissue Eng Part A 2010;16:2161-82
   PubMed Web of Science ®Google Scholar
• de Peppo GM, Sladkova M, Sjövall P, et al. Human embryonic stem cell-derived mesodermal progenitors display substantially increased tissue formation compared to human mesenchymal stem cells under dynamic culture conditions in a packed bed/column bioreactor. Tissue Eng Part A 2013;19:175-87
   PubMed Web of Science ®Google Scholar
• Grayson WL, Fröhlich M, Yeager K, et al. Engineering anatomically shaped human bone grafts. Proc Natl Acad Sci USA 2010;107:3299-304
   PubMed Web of Science ®Google Scholar
• Marolt D, Campos IM, Bhumiratana S, et al. Engineering bone tissue from human embryonic stem cells. Proc Natl Acad Sci USA 2012;109:8705-9
   PubMed Web of Science ®Google Scholar
• de Peppo GM, Marcos-Campos I, Kahler DJ, et al. Engineering bone tissue substitutes from human induced pluripotent stem cells. Proc Natl Acad Sci USA 2013;110:8680-5
   PubMed Web of Science ®Google Scholar
• Grayson WL, Marolt D, Bhumiratana S, et al. Optimizing the medium perfusion rate in bone tissue engineering bioreactors. Biotechnol Bioeng 2011;108:1159-70
   PubMed Web of Science ®Google Scholar
• Kuroda T, Yasuda S, Kusakawa S, et al. Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells. PLoS One 2012;7:e37342
   PubMedGoogle Scholar
• Schriebl K, Satianegara G, Hwang A, et al. Selective removal of undifferentiated human embryonic stem cells using magnetic activated cell sorting followed by a cytotoxic antibody. Tissue Eng Part A 2012;18:899-909
   PubMed Web of Science ®Google Scholar
• Tsigkou O, Pomerantseva I, Spencer JA, et al. Engineered vascularized bone grafts. Proc Natl Acad Sci USA 2010;107:3311-16
   PubMed Web of Science ®Google Scholar
• Salter E, Goh B, Hung B, et al. Bone tissue engineering bioreactors: a role in the clinic? Tissue Eng Part B Rev 2012;18:62-75
   PubMedGoogle Scholar
• Guha P, Morgan JW, Mostoslavsky G, et al. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 2013;12:407-12
   PubMed Web of Science ®Google Scholar
• Osafune K, Caron L, Borowiak M, et al. Marked differences in differentiation propensity among human embryonic stem cell. Nat Biotechnol 2008;26(3):313-15.
   PubMed Web of Science ®Google Scholar
• Bock C, Kiskinis E, Verstappen G, et al. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 2011;144:439-52
   PubMed Web of Science ®Google Scholar
• Jung Y, Bauer G, Nolta JA. Concise review: induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 2012;30:42-7
   PubMed Web of Science ®Google Scholar
• Brévignon-Dodin L. Regulatory enablers and regulatory challenges for the development of tissue-engineered products in the EU. Biomed Mater Eng 2010;20:121-6
   PubMed Web of Science ®Google Scholar
• Tasoglu S, Demirci U. Bioprinting for stem cell research. Trends Biotechnol 2013;31:10-19
   PubMed Web of Science ®Google Scholar
• Archer R, Williams DJ. Why tissue engineering needs process engineering. Nat Biotechnol 2005;23:1353-5
   PubMed Web of Science ®Google Scholar
• Martin I, Wendt D, Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnol 2004;22:80-6
   PubMed Web of Science ®Google Scholar